Ai-developed Lung Drug Shows Promise in Reversing Aging Signs

The drug, which was designed with the help of AI, targets a protein linked to both pulmonary fibrosis and the aging process. In laboratory tests on human cells and animal models, the treatment reduced markers of cellular senescence and improved tissue function. Researchers said the findings suggest the compound could one day be repurposed to address age-related decline, though further clinical trials are needed to confirm its safety and effectiveness in humans.